Skip to main content

Table 4 Gene change comparing EA inhibitory group with non-acupoint group

From: Effect of electroacupuncture stimulation at Zusanli acupoint (ST36) on gastric motility: possible through PKC and MAPK signal transduction pathways

Signal pathway Gene Sites EA/Non-acupoint (Fold change) EA/Non-acupoint (Fold up- or down-regulation)
MAPK MAPK6 (ERK3) D02 0.18 -5.67
MAPK MAPK10 (JNK3) D07 0.42 -2.40
MAPK MAPK11 (p38bMAPK) D08 0.39 -2.58
MAPK MAPK13 D10 0.28 -3.58
MAPK MAPK3 (ERK1) G11 0.26 -3.83
MAPK MAPK14 (p38MAPK) D11 0.47 -2.13
PKC FGF2 F07 0.37 -2.67
PKC IL1R1 F08 0.30 -3.31
PKC IL1R2 F09 0.36 -2.81
PKC MMP9 F11 0.22 -4.48
PKC MYC F12 0.39 -2.59
PKC PRKCA G01 0.23 -4.27
PKC PTGS2 G02 0.19 -5.36
PKC COL1A1 F05 4.81 4.81
  1. Fold-change (2-ΔΔCt) is the normalized gene expression (2-ΔCt) in the test sample divided by the normalized gene expression (2-ΔCt) in the control sample. Fold-regulation represents the fold-change results in a biologically meaningful way. Fold-change values greater than one indicate a positive- or up-regulation, and the fold-regulation is equal to the fold-change. Fold-change values less than one indicate a negative or down-regulation, and the fold-regulation is the negative inverse of the fold-change.